机器人辅助荧光示踪前哨淋巴结识别在早期结肠癌中的应用
这项前瞻性可行性研究纳入10例cT1-2N0M0结肠癌患者,在结肠镜下黏膜下注射吲哚菁绿(ICG),利用达芬奇Xi机器人近红外荧光模式行前哨淋巴结识别(SLNi),随后行段结肠切除。所有患者均检出至少1枚前哨淋巴结,无示踪剂相关不良事件,结论为安全可行。
要点
- 10例cT1-2N0M0结肠癌患者均成功检出至少1枚前哨淋巴结,平均2.3枚。
- 无示踪剂相关不良事件,中位结肠镜时间12分钟,检出时间6分钟,总SLNi时间30.5分钟。
- 2例前哨淋巴结存在转移,无假阴性;半数患者意外为pT3期。
核心结论
- 对10例cT1-2N0M0结肠癌患者行黏膜下注射ICG的机器人辅助荧光引导SLNi安全可行。
- SLNi在可接受的时间范围内完成,可检出小至1毫米的前哨淋巴结。
- 若行前哨淋巴结活检,所有淋巴结转移均会被检出。
研究设计与样本
- 前瞻性可行性研究,连续纳入10例cT1-2N0M0结肠癌患者。
- 术中在结肠镜下黏膜下瘤周注射ICG,使用达芬奇Xi机器人近红外荧光「Firefly」模式行SLNi。
- 前哨淋巴结缝线标记后行段结肠切除,术后对前哨淋巴结行连续切片和免疫组化超分期检查。
主要发现
- 所有患者均检出至少1枚前哨淋巴结,平均2.3枚,前哨淋巴结直径范围1-13毫米。
- 无示踪剂相关不良事件。
- 中位结肠镜时间12分钟,检出时间6分钟,总SLNi时间30.5分钟。
- 2例患者前哨淋巴结存在转移,无假阴性患者。
- 无患者因标准病理检查初始阴性后前哨淋巴结超分期而升级分期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with cT1-2 colon cancer (CC) have a 10-20% risk of lymph node metastases. Sentinel lymph node identification (SLNi) could improve staging and reduce morbidity in future organ-preserving CC surgery. This pilot study aimed to assess safety and feasibility of robot-assisted fluorescence-guided SLNi using submucosally injected indocyanine green (ICG) in patients with cT1-2N0M0 CC. METHODS: Ten consecutive patients with cT1-2N0M0 CC were included in this prospective feasibility study. Intraoperative submucosal, peritumoral injection of ICG was performed during a colonoscopy. Subsequently, the near-infrared fluorescence 'Firefly' mode of the da Vinci Xi robotic surgical system was used for SLNi. SLNs were marked with a suture, after which a segmental colectomy was performed. The SLN was postoperatively ultrastaged using serial slicing and immunohistochemistry, in addition to the standard pathological examination of the specimen. Colonoscopy time, detection time (time from ICG injection to first SLNi), and total SLNi time were measured (time from the start of colonoscopy to start of segmental resection). Intraoperative, postoperative, and pathological outcomes were registered. RESULTS: In all patients, at least one SLN was identified (mean 2.3 SLNs, SLN diameter range 1-13 mm). No tracer-related adverse events were noted. Median colonoscopy time was 12 min, detection time was 6 min, and total SLNi time was 30.5 min. Two patients had lymph node metastases present in the SLN, and there were no patients with false negative SLNs. No patient was upstaged due to ultrastaging of the SLN after an initial negative standard pathological examination. Half of the patients unexpectedly had pT3 tumours. CONCLUSIONS: Robot-assisted fluorescence-guided SLNi using submucosally injected ICG in ten patients with cT1-2N0M0 CC was safe and feasible. SLNi was performed in an acceptable timespan and SLNs down to 1 mm were detected. All lymph node metastases would have been detected if SLN biopsy had been performed.
引用
- Sikkenk DJ, Sterkenburg AJ, Burghgraef TA, et al. Robot-assisted fluorescent sentinel lymph node identification in early-stage colon cancer. Surg Endosc. 2023. PMID: 37721591. doi:10.1007/s00464-023-10394-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。